Phase 2a Study of VTX3232 in Parkinson's Disease

Clinical trial NCT06556173 · COMPLETED

Trial details

NCT number: NCT06556173
Sponsor: Zomagen Biosciences Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson Disease

Start date: 2024-08-08
Primary completion: 2025-04-04
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.